本頁面由Tiger Trade Technology Pte. Ltd.提供服務

奧麥羅製藥

17.34
+0.17000.99%
盤後17.350.0100+0.06%19:41 EDT
成交量:210.81萬
成交額:3,700.43萬
市值:12.55億
市盈率:11.04
高:17.99
開:17.16
低:17.15
收:17.17
52周最高:19.65
52周最低:3.94
股本:7,237.54萬
流通股本:6,825.80萬
量比:1.48
換手率:3.09%
股息:- -
股息率:- -
每股收益(TTM):1.57
每股收益(LYR):-0.0527
淨資產收益率:-576.33%
總資產收益率:-18.68%
市淨率:-24.44
市盈率(LYR):-328.74

資料載入中...

2021/05/20

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/08/14

重要事件披露

8-K - Current report
2020/08/12

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report